Sign inJoin waitlistJoin the waitlist

Edus Warren

Professor, Translational Science and Therapeutics Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Medical Oncology
1996–1998
Internal Medicine
University of Washington-Seattle Campus
1993–1996
Internal Medicine
Massachusetts General Hospital
1991–1993
Neurobiology; Harvard University
Harvard Medical School
1987–1991
Applied Mathematics; Harvard College
1978–1982

Research

Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells
Blood · 2009 · 959 citations
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Blood · 2011 · 552 citations
Overlap and effective size of the human CD8+ T cell receptor repertoire
Science Translational Medicine · 2010 · Last of 8 authors · 306 citations

Stanley Riddell
34 papers
Paul Martin
23 papers
Ajay Gopal
17 papers
Scott Tykodi
17 papers · 2 as a fellow
Mazyar Shadman
16 papers
Ryan Lynch
16 papers
Stephen Smith
16 papers
Chaitra Ujjani
15 papers
David Coffey
15 papers
John Hansen
13 papers
Brian Till
12 papers
Mary Flowers
12 papers

Grants

Comprehensive Characterization of the T-Cell Response to KSHV to Enable Specific Immune Therapy
National Cancer Institute · U01
Contact PI · $4.4M · Fred Hutchinson Cancer Center
2025–2029
Training in Cancer Genomics and Genomic Data Science
National Cancer Institute · D43
Contact PI · $768.9K · Fred Hutchinson Cancer Center
2022–2029
HIV Persistence and Treatment Response in Kaposi Sarcoma
National Cancer Institute · R21
Contact PI · $432.1K · Fred Hutchinson Cancer Center
2025–2027
Building Independent Research Leaders in HIV-Associated Malignancies in Uganda
Fogarty International Center · D43
PI · $1.5M · Fred Hutchinson Cancer Center
2014–2026

Clinical trials

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
Principal investigator · Completed · Phase 1
Fred Hutchinson Cancer Center
1998